Press Releases May 4, 2026 09:00 AM

Coca-Cola Consolidated To Invest $35 Million in Indianapolis Manufacturing Facility

Coca-Cola Consolidated commits $35 million to expand Indianapolis manufacturing with new glass bottle production line.

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
COKE

Coca-Cola Consolidated announced a $35 million investment to add a new glass bottle production line at its Indianapolis facility, expected to begin construction in late 2026. The expansion will create 15 to 20 new full-time jobs and boost local economic activity. This reinforces Indianapolis as a key production hub within the Coca-Cola System and enhances the company’s manufacturing capabilities and sustainability efforts.

Coca-Cola Consolidated To Invest $35 Million in Indianapolis Manufacturing Facility
COKE
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • $35 million investment to add a new glass bottle production line in Indianapolis, starting late 2026.
  • Expansion expected to create 15 to 20 new full-time jobs and stimulate local economic activity.
  • Indianapolis facility becomes one of only three in the US to bottle beverages in glass, reinforcing its strategic importance within Coca-Cola System.

INDIANAPOLIS, May 04, 2026 (GLOBE NEWSWIRE) -- Coca-Cola Consolidated is deepening its long-term commitment to Indianapolis with a $35 million investment that will expand local manufacturing capabilities. 

The company plans to add a new bottle production line to its Indianapolis facility located at 5000 W. 25th Street specifically for bottling beverages in glass bottles. Construction of the new line is anticipated to begin in late 2026. This expansion is expected to create 15 to 20 new full-time jobs and initiate additional economic activity through construction, suppliers, and local services. This local investment by Coca-Cola Consolidated positions Indianapolis as a key production hub within the Coca-Cola System, making this facility one of only three in the nation to bottle beverages in glass.

“This expansion is another example of how we strategically invest in our business to build a solid operational foundation and create opportunities for our teammates in the communities where they live and work,” said Dave Katz, President and Chief Operating Officer at Coca-Cola Consolidated. “We are excited about the impact this investment will have in the local community and look forward to continuing our long-standing relationships with dedicated community partners.”

Operating since 1968, the Indianapolis facility currently houses four production lines, two PET and rPET bottle lines and two can lines. It also includes a production warehouse and champions the company’s sustainability focus areas. Coca-Cola Consolidated currently employs more than 1,200 teammates in the state of Indiana working in 9 facilities serving more than 17,500 businesses.

About Coca-Cola Consolidated, Inc.:

Headquartered in Charlotte, N.C., Coca-Cola Consolidated (NASDAQ: COKE) is the largest Coca-Cola bottler in the United States. We make, sell and distribute beverages of The Coca-Cola Company, and other partner companies, in more than 300 brands and flavors across 14 states and the District of Columbia, to approximately 60 million consumers.

For over 124 years, we have been deeply committed to the consumers, customers and communities we serve and passionate about the broad portfolio of beverages and services we offer. Our Purpose is to honor God in all we do, to serve others, to pursue excellence and to grow profitably.

More information about the Company is available at www.cokeconsolidated.com. Follow Coca-Cola Consolidated on Facebook, X, Instagram and LinkedIn.

Contact: 
Ashley Brown, APR
Director of External Communications
Ashley.Brown@cokeconsolidated.com 


Risks

  • Delays or cost overruns in construction could impact the timeline and financial benefits of the expansion.
  • Changes in consumer demand for glass-bottled beverages may affect the investment return.
  • Potential supply chain disruptions could impact production capacity or cost efficiency during and after expansion.

More from Press Releases

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 Jun 14, 2026 Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026 Jun 14, 2026 Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control Jun 14, 2026 Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026 Jun 14, 2026